Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Rapamycin in Advanced Polycystic Kidney Disease Pilot Study
Brief Summary: The purpose of this study is to evaluate the safety of a daily single oral dose of sirolimus in patients with advanced autosomal dominant polycystic kidney disease.